Marathi | HIndi

Epaper
Follow us:
Home > Topic >Gilead > news
Gilead

Gilead

Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs.

Read more
Fresh guidelines for Remdesivir injection for private hospitals treating govt patients in Karnataka
National

Fresh guidelines for Remdesivir injection for private hospitals treating govt patients in Karnataka

The Karnataka government has said that while Remdesivir injections have already been used in government hospitals, the same benefits will be extended to the patients referred through the government to private hospitals.

EU signs deal on Remdesivir supply for COVID-19 treatment
Health

EU signs deal on Remdesivir supply for COVID-19 treatment

Brussels, July 30 The European Commission said that it has signed a 63 million-euro contract with American pharmaceutical ...

Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
Business

Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial

Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial.

India to soon begin domestic production of Remdesivir drug to fight COVID-19
National

India to soon begin domestic production of Remdesivir drug to fight COVID-19

India is soon going to have its domestic production of anti-viral Remdesivir drug, which would have safety, efficacy and stability for "restricted emergency use" on COVID-19 patients.

COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on hospitalised patients
National

COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on hospitalised patients

In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergency use" on hospitalized COVID19 patients, according to a senior government official.

How Singapore, India are contributing to a COVID-19 vaccine race
International

How Singapore, India are contributing to a COVID-19 vaccine race

With the COVID-19 cases zipping past five million people globally last week and rocketing towards six million, the search for a vaccine and a therapy has become more and more urgent.

B'desh produces 1st generic version of remdesivir
International

B'desh produces 1st generic version of remdesivir

Bangladesh-based Beximco Pharmaceuticals has become the worlds first company to produce a generic version of the antiviral drug remdesivir, ...

Gilead in talks with Indian drugmakers to produce remdesivir for treatment of COVID-19
Business

Gilead in talks with Indian drugmakers to produce remdesivir for treatment of COVID-19

Producing the drug requires scarce raw materials, with their own lengthy production time, and specialised manufacturing capabilities with limited global capacity.Any disruption to the supply chain impacting these scarce raw materials and other manufacturing inputs could reduce the amount of remdesivir produced and increase the time it takes to do so.

US preparing to treat seriously ill COVID-19 patients with Remdesivir
Health

US preparing to treat seriously ill COVID-19 patients with Remdesivir

The medication, recently given fast-track approval for use in the US, could be administered apart from clinical trials as early as Monday to the first coronavirus patients, while manufacturer Gilead is making plans to export it to other nations who give it the green light, reports Efe news."We intend to get that to patients in the early part of this next week, beginning to work with the government, which will determine which cities are most vulnerable and where the patients are that need this medicine." The California-based Gilead has its "entire supply" of 1.5 million doses of Remdesivir, which could be used to treat "100,000 to 200,000" patients, depending on their various conditions over the next "five or 10 days", O'Day said.Gilead has accelerated its production of the antiviral and last week said that it was confident it would have "several million" doses available by the end of this year, a supply that could be used for patients in this country and others.

Antiviral drug -- Remdesivir -- is next big thing in fight against COVID-19: Former ICMR DG Dr Ganguly
National

Antiviral drug -- Remdesivir -- is next big thing in fight against COVID-19: Former ICMR DG Dr Ganguly

As per the experts, antiviral drug -- Remdesivir -- could be the answer.Commenting on the drawbacks of this drug, Ganguly said: "The only drawback noted so far is that it has to be given through infusion."After the results are known, India will be able to use this drug as this is the largest randomised chemical trial," added Dr Ganguly.However, it does not mean we cannot carry out trials with this drug," said Dr Ganguly.

Most Popular Stories